Renal Denervation Technologies Market is expected to witness a prolific CAGR over the 2022-2026 forecast period.
08 Sep 2022
Demand for renal denervation procedures is anticipated to be aided by various authorities and government organizations increasing funding for R&D initiatives for renovascular hypertension treatment.
Fact.MR – A Market Research and Competitive Intelligence Provider: Renal Denervation technologies have witnessed impressive growth in the past due to surge in prevalence of hypertension patients. Moreover, market is also driven by its minimally-invasive procedure for hypertension treatments.
Renal denervation is a microsurgical solution for hypertension. Radiofrequency ablation is the process that helps burning the neurons in the renal arteries. Once blood pressure is reduced, nerve stimulation is decreased. This is commonly used to get better results when drug treatment hasn't worked to relieve symptoms.
With the help of ultrasound or radiofrequency pulses, the nerves that line the renal artery wall are destroyed. Moreover, a reduction in sympathetic kidney activity lowers blood pressure. Also, the renal denervation devices are expected to witness high demand due to rising prevalence of chronic disorders including obesity in both, children and adults.
As per the statistic from World Health Organization (WHO), more than 39 million children under the age of five were overweight in 2020. Also, high leptin levels in obese individuals might lead to hypertension by stimulating the formation of blood vessels in the hypothalamus.
For more insights into the Market, Request Brochure of this Report
However, inadequate clinical data is one of the factors restricting the growth of renal denervation technologies market, which makes it challenging to obtain regulatory body approval for new products. Moreover, market is also restricted due to lack of skilled professionals. Moreover, risk of infection following surgery is one of the main concerns that can limit the demand.
But, introduction of new products in this area is expected to aid the expansion of the market. Also, the surge in prevalence of drug-resistant hypertension cases in various regions such as North America, Europe could drive the growth of the market.
Market Trends:
Surge in funding for treatment of renal disorders
Various government authorities and organizations are increasing funding for R&D initiatives for renovascular hypertension treatment. Moreover, advancements in the devices could also fuel the growth of the industry.
Apart from this, various factors that are boosting the adoption of the renal denervation method is that it lessens the renal artery injury. Various patients because of its effectiveness prefer this method. Moreover, government organizations are incorporating technology into these kinds of health practices and also offering opportunities in renal denervation industry.
For Comprehensive Insights Ask An Analyst Here
New entrants attempting to create reliable systems
New market entrants are focusing on technological advancements in Renal Denervation Technologies. Moreover, new companies are continuously focus on reliable systems for reducing the difficulties associated with high blood pressures and hypertension.
For instance, A start-up based in Israel – SoniVie - received FDA approval for its novel treatment for hypertension. Moreover, patients with hypertension can benefit from renal artery denervation using the advanced ultrasound technology TIVUS. Moreover, the main treatment made available by TIVUS, renal denervation, is a minimally invasive surgery that safely ablates renal artery nerves using high frequency, non-focused ultrasound energy. Moreover, this process lowers blood pressure by reducing nerve activity.
Regional Market Growth Avenues
Europe is expected to dominate the renal denervation technologies market. As per a research study, Over 40% of Europeans over the age of 25 have hypertension, and 10% of those have medication-resistant hypertension.
Moreover, numerous renal denervation activities with CE authorization are available in Europe. Also, growing R&D efforts to create effective technologies for renal artery stenosis are the main drivers boosting the market expansion.
In the meanwhile, increased incidences of uncontrolled hypertension, changing lifestyle among the populace are expected to fuel market expansion in the US.
Also, rapid growth of uncontrolled hypertension caused by rapid urbanization, and an increase in FDA approvals are major factors contributing to the market growth in the United States.
Get Customization on this Report for Specific Research Solutions
More Insights Available
Fact.MR offers a unique perspective and actionable insights on the coatings for Renal Denervation Technologies Market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on the basis of Product (Symplicity, Vessix, EnligHTN, ParadiseI, beris & Others) By Technology (Radiofrequency-based, Ultrasound-based & Micro-infusion-based) By End-User and By Region – Global Market Insights 2022 to 2026
Explore Fact.MR’s Coverage on the Healthcare Domain
Renal Artery Stenosis Treatment Market - Renal artery stenosis is the narrowing of the renal artery that carries blood to the kidneys. The narrowing of the renal artery obstructs blood flow, resulting in renovascular hypertension, high blood pressure, and kidney damage. Atherosclerosis and fibromuscular dysplasia are the major causes of renal artery stenosis.
Renal Artery Embolization Market - The renal arteries take a large volume of blood to be filtered by the kidneys. The renal artery embolization technique is used mainly to treat urological and neurological diseases. The renal artery embolization technique is a minimal invasive procedure that terminates the blood flow completely or partially.
Renal Drugs Market - Renal diseases are becoming a significant health issue among the general population. Renal drugs are majorly used for kidney disease treatment. The treatment for kidney diseases totally depends on the stage of chronic kidney disease. The main treatments which are generally provided for chronic kidney disease are lifestyle changes, renal drugs, dialysis, and kidney transplantation.
Renal Denervation Technologies Market - Demand for radiofrequency-based technology is expected to increase at 35% CAGR over the coming years. It is anticipated that the excellent efficacy of radiofrequency-based technology, which has been demonstrated in various trials, would boost the significance of these devices across geographies.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.